Molecular testing in colorectal cancer: diagnosis of Lynch syndrome and personalized cancer medicine

American Journal of Clinical Pathology
Chanjuan Shi, Kay Washington

Abstract

Currently, molecular testing in colorectal cancer (CRC) is aimed at detecting Lynch syndrome and predicting response to anti-epidermal growth factor receptor (EGFR) therapies. However, CRC is a complex disease, with at least 3 molecular pathways of carcinogenesis. The importance of the EGFR signaling pathway in colorectal carcinogenesis is underscored by the availability of anti-EGFR monoclonal antibodies for the treatment of some metastatic CRCs. Potentially, mutations in any of the genes in the EGFR signaling pathway may be associated with prognosis and may predict response to anti-EGFR or other targeted therapies. Although not currently the standard of care, molecular testing of CRCs is expanding to include mutational analysis of the genes in the EGFR pathway, in addition to more widely performed tests for identifying cancers with high microsatellite instability. Multiplex molecular prognostic panels for therapeutic decision making in stage II CRCs also represent expanding use of molecular testing for this common cancer.

References

Sep 1, 1988·The New England Journal of Medicine·B VogelsteinJ L Bos
Oct 18, 1996·Cell·K W Kinzler, B Vogelstein
Jun 26, 1999·Gastroenterology·J M CarethersC R Boland
Dec 23, 1999·Human Molecular Genetics·G GuantiM Gentile
Feb 13, 2001·The American Journal of Pathology·J AlexanderS R Hamilton
Apr 20, 2001·The New England Journal of Medicine·T WatanabeS R Hamilton
Sep 5, 2001·British Journal of Cancer·H J AndreyevN Urosevic
Jan 22, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Guoren DengYoung S Kim
Feb 6, 2004·Gastroenterology·John M CarethersC Richard Boland
Feb 19, 2004·Journal of the National Cancer Institute·Asad UmarSudhir Srivastava
Mar 3, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Leonard B SaltzRobert J Mayer
Mar 16, 2004·Science·Yardena SamuelsVictor E Velculescu
Jun 17, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Al B BensonDaniel G Haller
Jul 23, 2004·The New England Journal of Medicine·David CunninghamEric Van Cutsem
Dec 31, 2004·The New England Journal of Medicine·Thomas D BarberVictor E Velculescu
Jan 22, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S PopatR S Houlston
Jan 29, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ki Young ChungLeonard B Saltz
Mar 5, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Hisashi NagaharaMasaki Mori
Apr 16, 2005·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Jinru ShiaBeiyun Chen
Apr 28, 2005·JAMA : the Journal of the American Medical Association·Noralane M LindorDaniela Seminara
May 6, 2005·The New England Journal of Medicine·Heather HampelAlbert de la Chapelle
Jul 5, 2005·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Sérgia VelhoRaquel Seruca
Jul 7, 2005·Journal of the National Cancer Institute·William L InceHartmut Koeppen
Jul 19, 2005·Cancer Research·Wade S SamowitzMartha L Slattery
Dec 3, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Piero BenattiGiovanni Lanza
Apr 19, 2006·Cancer Research·Astrid LièvrePierre Laurent-Puig
Sep 14, 2006·Cancer Biology & Therapy·Sarah EdkinsP Andrew Futreal
Feb 8, 2007·Journal of the National Cancer Institute·Rosa M XicolaUNKNOWN Gastrointestinal Oncology Group of the Spanish Gastroenterological Association
Jun 26, 2007·International Journal of Cancer. Journal International Du Cancer·Shunsuke KatoKenichi Sugihara
Aug 1, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Shirin Khambata-FordDavid J Mauro
Oct 13, 2007·Science·Laura D WoodBert Vogelstein
Oct 18, 2007·British Journal of Cancer·M FrattiniL Mazzucchelli
Dec 18, 2007·Lancet·UNKNOWN Quasar Collaborative GroupDavid J Kerr
Dec 22, 2007·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Xavier BessaUNKNOWN Gastrointestinal Oncology Group of Spanish Gastroenterological Association

❮ Previous
Next ❯

Citations

Sep 18, 2013·Cancer Genetics·Jennifer HutchisonMark A Nelson
Oct 27, 2012·International Journal of Colorectal Disease·Gangmi KimNam Kyu Kim
Mar 14, 2013·Expert Opinion on Medical Diagnostics·Henry T LynchStephen Lanspa
Jul 2, 2016·Therapeutic Advances in Gastroenterology·Eihab AbdelfatahNita Ahuja
Jan 7, 2015·World Journal of Gastroenterology : WJG·Hans RaskovJacob Rosenberg
Feb 6, 2016·Advances in Anatomic Pathology·Raju K PillaiScott D Patterson
Oct 14, 2019·Journal of Pathology and Translational Medicine·Miseon LeeJihun Kim
May 14, 2016·PloS One·Yandiswa Yolanda YakoMartin Brand
Jul 25, 2021·British Journal of Cancer·Alexandra M ZaborowskiLydia Lynch

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.